<SEC-DOCUMENT>0001209191-21-023286-index.html : 20210326
<SEC-HEADER>0001209191-21-023286.hdr.sgml : 20210326
<ACCEPTANCE-DATETIME>20210326180946
ACCESSION NUMBER:		0001209191-21-023286
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210324
FILED AS OF DATE:		20210326
DATE AS OF CHANGE:		20210326

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Auffarth Gerd
		CENTRAL INDEX KEY:			0001649867

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37759
		FILM NUMBER:		21778900

	MAIL ADDRESS:	
		STREET 1:		C/O PRESBIA PLC
		STREET 2:		120/121 BAGGOT STREET LOWER
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			00000

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Outlook Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001649989
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				383982704
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	BUSINESS ADDRESS:	
		STREET 1:		4260 U.S. ROUTE 1
		CITY:			MONMOUTH JUNCTION
		STATE:			NJ
		ZIP:			08852
		BUSINESS PHONE:		6096193990

	MAIL ADDRESS:	
		STREET 1:		4260 U.S. ROUTE 1
		CITY:			MONMOUTH JUNCTION
		STATE:			NJ
		ZIP:			08852

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oncobiologics, Inc.
		DATE OF NAME CHANGE:	20150804
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
Document 1 - file: doc4.html

Document 1 - RAW XML: doc4.xml

</DOCUMENT>
</SEC-DOCUMENT>